IRIS
LODI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.208
EU - Europa 3.616
AS - Asia 1.556
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
SA - Sud America 3
Totale 9.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.121
CN - Cina 1.229
IE - Irlanda 804
SE - Svezia 671
IT - Italia 581
FI - Finlandia 537
UA - Ucraina 477
DE - Germania 330
SG - Singapore 155
TR - Turchia 126
GB - Regno Unito 90
CA - Canada 85
FR - Francia 36
BE - Belgio 32
NL - Olanda 15
ES - Italia 13
IN - India 12
CZ - Repubblica Ceca 9
CI - Costa d'Avorio 8
EU - Europa 7
HK - Hong Kong 6
IR - Iran 6
VN - Vietnam 6
JP - Giappone 5
PH - Filippine 5
RO - Romania 4
RU - Federazione Russa 4
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
KR - Corea 2
MK - Macedonia 2
NG - Nigeria 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ID - Indonesia 1
LV - Lettonia 1
MC - Monaco 1
ME - Montenegro 1
MX - Messico 1
RS - Serbia 1
Totale 9.407
Salva come PNG Salva come JPEG
Città #
Dublin 792
Chandler 791
Jacksonville 537
Ashburn 297
Ann Arbor 282
Dearborn 282
Beijing 257
Nanjing 209
Parma 176
Princeton 155
San Mateo 132
Izmir 123
Wilmington 118
Shanghai 103
Jinan 74
Toronto 73
New York 71
Shenyang 70
Boardman 69
Singapore 67
Nanchang 61
Los Angeles 56
Hefei 55
Des Moines 54
Kunming 51
Helsinki 50
Woodbridge 50
Hebei 48
Brussels 30
Falls Church 30
Jiaxing 30
Guangzhou 29
Dosolo 26
Tianjin 25
Changsha 24
Seattle 23
Houston 20
Redmond 18
Zhengzhou 17
Bremen 16
Haikou 16
Padova 15
Fremont 14
Fuzhou 14
Hangzhou 14
Taizhou 13
Bologna 12
Modena 11
Norwalk 11
Redwood City 11
Lanzhou 10
Rockville 10
Auburn Hills 9
Dallas 9
Rome 9
Abidjan 8
Almería 8
Borås 8
Milan 8
Phoenix 8
Chongqing 7
Grafing 7
Gravina di Catania 7
Xian 7
Amsterdam 6
Cordovado 6
Dong Ket 6
Messina 6
Pavia 6
Pune 6
Santa Clara 6
Sorbolo 6
Taiyuan 6
Wenzhou 6
Wuhan 6
Davao City 5
Düsseldorf 5
Fairfield 5
Piacenza 5
Scafati 5
Ardea 4
Avola 4
Brescia 4
Dronten 4
Las Vegas 4
Madrid 4
Montreal 4
Perugia 4
Quzhou 4
San Remo 4
Vancouver 4
Washington 4
Zanjan 4
Afragola 3
Cairo 3
Cambridge 3
Cesenatico 3
Este 3
Huzhou 3
Leawood 3
Totale 5.801
Salva come PNG Salva come JPEG
Nome #
DNA polymerase [gamma] and disease: what we have learned from yeast 108
Construction and validation of a yeast model system for studying in vivo the susceptibility to stavudine of DNA polymerase gamma allelic variants 99
A chemical genomic approach to characterize the antiproliferative activity of metal based drugsdriven by phenotypic screening in yeast as a model organism 98
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 96
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 96
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 95
Yeast, worm, patient’s fibroblasts and zebrafish as models for drug repositioning of molecules targeting POLG-related diseases 95
A Klaac null mutant of Kluyveromyces lactis is complemented by a single copy of the Saccharomyces cerevisiae AAC1 gene 93
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 92
IMP2, a nuclear gene controlling the mitochondrial dependence of galactose, maltose and raffinose utilization in Saccharomyces cerevisiae. 90
Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island 90
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 89
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 88
Behaviour of Saccharomyces cerevisiae wine strains during adaptation to unfavourable conditions of fermentation on synthetic medium: Cell lipid composition, membrane integrity, viability and fermentative activity 87
S. cerevisiae carrying a MGM1/OPA1 chimeric gene: a model for the study of dominant optic atrophy and for drug discovery 87
In vitro evaluation of the activity of thiosemicarbazone derivatives against mycotoxigenic fungi affecting cereals 86
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations 86
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 85
Mechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study 85
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 85
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models 85
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 84
Screening of thiosemicarbazones as antimycotic drugs 83
Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of Clofilium tosylate as a potential therapeutic chemical against POLG-related diseases 83
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 83
Characterization of a promoter mutation in the CYP3 gene of S. cerevisiae which cancels regulation by Cyp1p (Hap1p) without affecting its binding site 82
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 80
Construction and validation of a yeast model system for studying in vivo the susceptibility to stavudine of Polg allelic variants 79
Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy 79
Secretion of human serum albumin from Kluyveromyces lactis over-expressing KlPDI1 and KlERO1 genes 78
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 78
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 78
Structural modification of cuminaldehyde thiosemicarbazone increases inhibition specificity toward aflatoxin biosynthesis and sclerotia development in Aspergillus flavus 78
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 78
Amino and carboxy-terminal extensions of yeast mitochondrial DNA polymerase assemble both the polymerization and exonuclease active sites 77
Cloning and characterization of the lactate-specific inducible gene KlCYB2, encoding the cytochrome b2 of Kluyveromyces lactis 76
Klaac null mutant in K. lactis is complemented by a single copy of S. cerevisiae “silent” gene AAC1 76
A chemical genomic approach to characterize the antiproliferative activity of metal-based drugs driven by phenotipic screening in yeast as a model organism 76
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 76
Catabolite repression by galactose in overexpressed GAL4 strains of Saccharomyces cerevisiae 74
Allelism of IMP1 and GAL2 genes of Saccharomyces cerevisiae 74
“Espressione e secrezione di una Major Urinary Protein di topo nel lievito metilotrofo Pichia pastoris” 73
Chiral Aminoacid Containing Acyclic Ligands. I. Syntheses and Conformations 73
A mitochondrial role in pseudohyphal constitutive mutants obtained from a natural Saccharomyces cerevisiae strain 72
Overexpression of DNA Polymerase Zeta Reduces the Mitochondrial Mutability Caused by Pathological Mutations in DNA Polymerase Gamma in Yeast 72
Construction of a yeast model system for studying in vivo susceptibility to stavudine of Polg allelic variants 71
LYS2 gene and its mutation in Kluyveromyces lactis 70
Construction and characterization of centromeric, episomal and GFP-containing vectors for Saccharomyces cerevisiae prototrophic strains 70
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 70
“Expression and structural characterization of a recombinant mouse major urinary protein” 69
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 69
Elementi regolativi implicati nel processo di repressione /derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 68
“Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant Major Urinary Protein” 68
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 68
Effetti fenotipici e funzionali di mutazioni del gene ANT1 responsabili della patologia umana adPEO nel lievito Saccharomyces cerevisiae 67
L'aumento del dosaggio del gene ero1 favorisce la secrezione di proteine ricombinanti in Kluyveromyces lactis 67
Regolazione del gene JEN1, codificante la lattato permeasi, nel lievito Saccharomyces cerevisiae 66
Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant Major Urinary Protein 66
Construction and validation of a yeast model system for studying in vivo the susceptibility to nucleoside analogues of DNA polymerase gamma allelic variants. 66
Modeling of pathogenic variants of mitochondrial DNA polymerase: insight into the replication defects and implication for human disease 65
Comparative Functional Genomics of glucose repression in laboratory and wine yeasts 64
Carbon catabolite repression in Kluyveromyces lactis: isolation and characterization of the KlDLD gene encoding the mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. 64
Investigation of mupirocin susceptibility in bifidobacteria: physiological and genetic insights. 64
MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of IMP2p 63
A variable neurodegenerative phenotype with polymerase gamma mutation 63
Carboxylic acids permeases in yeast: two genes in Kluyveromyces lactis.” 63
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 63
Overexpression of DNA polymerase zeta and Rev1 reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast. 62
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 62
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 62
Yeast as a model for drug discovery: Identification of a molecule acting as potential therapeutics for POLG-related diseases 62
Klaac null mutant in K.lactis is complemented by a single copy of S.cerevisiae gene AAC1 61
Antimycin- and hydroxamate-insensitive respiration in yeast 61
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 61
Characterization of KlGUT2, a gene of the glycerol-3-phosphate shuttle, in Kluyveromyces lactis 60
Rescue by Pol zeta overexpression of mitochondrial DNA instability due to mutations in Pol gamma in S. cerevisiae 60
Overexpression of DNA polymerase zeta reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast. 60
Klaac null mutant in Kluyveromycs lactis is complemented by a single copy of Saccharomyces cerevisiae gene AAC1 60
Influence of leucine metabolism on Saccharomyces cerevisiae dimorphism 59
The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. 59
Yeast as a model for drug discovery: identification of a molecule acting as potential therapeutics for POLG-related diseases 59
“MAJOR URINARY PROTEINS: STUDIES ON THE BINDING OF FLUORESCENT MOLECULES AND ITS 13C AND 15N ENRICHED EXPRESSION IN PICHIA PASTORIS” 58
Lipid Metabolism Related To Stuck Fermentation In Saccharomyces cerevisiae Wine Strains 57
Identificazione dei bersagli della proteina Imp2p in Saccharomyces cerevisiae 57
Galactose transport in Kluyveromyces lactis: major role of the glucose permease Hgt1 57
Galactose transport in Kluyveromyces lactis: a genomic approach 57
Co-ordinated regulation of lactate metabolism genes in yeast: role of lactate permease gene JEN1 57
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 57
Modification of nuclear gene expression by inhibition of mitochondrial translation during sporulation in MATa/Mata diploids of Saccharomyces cerevisiae. 56
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 55
Il lievito come modello per lo studio di patologie mitocondriali umane 55
Elementi regolativi implicati nel processo di repressione/derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 55
FOG1 and FOG2 genes, required for the transcriptional activation of glucose-repressible genes of Kluyveromyces lactis are homologous to GAL83 and SNF1 of Saccharomyces cerevisiae 55
Yeast as a model for drug repositioning: analysis of molecules acting as potential therapeutics for POLG-related diseases 55
Il metabolismo lipidico di ceppi vinari di Saccharomyces cerevisiae e gli arresti di fermentazione 55
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 55
Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish 55
“La proteina feromonale Major Urinary Protein: struttura della proteina ricombinante ed indagini molecolari sull’organo sensoriale del sistema olfattivo feromonale” 54
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 54
Three target genes for the transcriptional activator Cat8p of Kluyveromyces lactis: acetyl coenzyme A synthetase genes KlACS1 and KlACS2 and lactate permease gene KlJEN1 54
Totale 7.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.798 0 353 134 20 162 237 257 61 239 170 44 121
2020/20211.141 22 119 111 26 154 40 138 45 229 41 172 44
2021/2022787 22 16 15 36 25 24 103 120 34 67 50 275
2022/20232.873 312 276 217 220 232 329 28 193 934 18 87 27
2023/20241.028 54 86 33 30 89 241 85 112 15 88 80 115
2024/202547 36 11 0 0 0 0 0 0 0 0 0 0
Totale 9.633